Download
https://www.ndtvprofit.com/research-reports/icici-direct-aurobindo-pharma-divestiture-of-dietary-supplement-business-natrol?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Aurobindo Pharma has signed a pact to sell its U.S.-based unit Natrol to New Mountain Capital and its affiliate for $500 million.
Share